Fabíola Giordani (Fabiola Giordani)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Cross Sectional

Top Venues

Cadernos de saude publica

Ciencia & saude coletiva

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Cristina Marques Martins, Fabíola Giordani, Mariana de Castro Gonçalves, Lusiele Guaraldo, Suely Rozenfeld
[Deaths from adverse drug events in Brazil: Mortality Information System as a source of information]. Cadernos de saude publica 38 (8) (2022)
Camille Nigri Cursino, Priscilla Garcia de Oliveira Monteiro, Gabriel da Silva Duarte, Tassita Bezz Quintanilha Vieira, Verônica de Carvalho Crisante, Fabíola Giordani, Ana Lucia Rampazzo Xavier, Renan Moritz Varnier Rodrigues de Almeida, Sabrina Calil-Elias
Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C. Pharmacoepidemiology and drug safety 28 (12) (2019)
Ana Cristina Marques Martins, Fabíola Giordani, Lusiele Guaraldo, Gianni Tognoni, Suely Rozenfeld
The authors reply. Cadernos de saude publica 35 (3) (2019)
Rafaela Teixeira Zorzanelli, Fabíola Giordani, Lusiele Guaraldo, Guacira Corrêa de Matos, Arnaldo Gomes de Brito Junior, Márcia Gonçalves de Oliveira, Renata de Morais Souza, Renata Quintão Mendes Mota, Suely Rozenfeld
Consumption of the benzodiazepine clonazepam (Rivotril®) in Rio de Janeiro State, Brazil, 2009-2013: an ecological study. Ciencia & saude coletiva 24 (8) (2019)
Janaina da Silva Santos, Fabíola Giordani, Maria Luiza Garcia Rosa
[Potential drug interactions in adults and the elderly in primary health care]. Ciencia & saude coletiva 24 (11) (2019)